Atrys Health SL (ATRY)

Madrid
Currency in EUR
3.58
+0.06(+1.70%)
Closed
ATRY Scorecard
Full Analysis
Operates with a significant debt burden
Fair Value
Day's Range
3.513.58
52 wk Range
2.774.48
Key Statistics
Edit
Bid/Ask
3.47 / 3.60
Prev. Close
3.52
Open
3.55
Day's Range
3.51-3.58
52 wk Range
2.77-4.48
Volume
16.98K
Average Volume (3m)
33.29K
1-Year Change
11.53%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ATRY Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
6.40
Upside
+78.77%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Atrys Health Company Profile

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic counselling; and diagnostic reports and genetic tests. It also provides telemedicine services, such as teleradiology, telecardiology, teleoncology, teledermatology, teleophthalmology, and teleconsultations; prevention plans for companies, which includes training plans on occupational risk prevention; Smart Data, a technological database for healthcare; and research and development services. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.

Employees
2084
Market
Spain

Compare ATRY to Peers and Sector

Metrics to compare
ATRY
Peers
Sector
Relationship
P/E Ratio
−8.6x14.3x−0.6x
PEG Ratio
−0.780.050.00
Price/Book
1.0x0.9x2.6x
Price / LTM Sales
1.3x0.5x3.1x
Upside (Analyst Target)
81.6%38.5%52.1%
Fair Value Upside
Unlock16.1%8.2%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 6.40
(+78.77% Upside)

Earnings

Latest Release
Nov 27, 2024
EPS / Forecast
-- / --
Revenue / Forecast
48.60M / 46.00M
EPS Revisions
Last 90 days

FAQ

What Is the Atrys Health (ATRY) Stock Price Today?

The Atrys Health stock price today is 3.58.

What Stock Exchange Does Atrys Health Trade On?

Atrys Health is listed and trades on the Madrid stock exchange.

What Is the Stock Symbol for Atrys Health?

The stock symbol for Atrys Health is "ATRY."

What Is the Atrys Health Market Cap?

As of today, Atrys Health market cap is 271.85M.

What is Atrys Health Earnings Per Share?

The Atrys Health EPS is -0.514.

What Is the Next Atrys Health Earnings Date?

Atrys Health will release its next earnings report on 25 Feb 2025.

From a Technical Analysis Perspective, Is ATRY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.